Open Access Open Access  Restricted Access Subscription Access

DRUGS ACTING ON GOUT AND DRUGS TARGETING ACID METABOLISM

Muralinath E., Pooja Devi, Prasanta Chbukdhara, Sanjib Borah, Kalyan C., Archana Jain, Guruprasad M.

Abstract


Gout occurs due to the accumulation of uric acid crystals particularly in the joints and results in discomfort, pain and swelling. Non steroidal anti _ inflammatimiry drugs ( NSAID) Research involved for the management of a ute gout attacks. Indomethacin and naproxen decrease pain and decrease inflammation by stopping the production of inflammatory compounds. Colchicine shows its activity regarding treatment of acute gout attacks by decreasing inflammation and decreasrsthe movement of leukocytes to the affected joint. Colchine leads to the occurrence of side effects. Sometimes corticosteroids are administered orally or injected into the affected joint to decreasevpain and inflammation. Allopurinol, febuxodtat and xanthine inhibitors decrease uric acid levels by stopping this enzyme. Uricosuric agents namely probenecid perform by enhancing the excretion of uric acid through the kidneys. Lesinurad is useful regarding gout inhibitor, primarily targeting the URAT _1 transporter in the kidneys.  Pegloticase is an enzyme replacement therapy that breakdown uric acid into a more soluble form. it is finally concluded that medications impacting uric acids metabolism, namely xanthine oxidase inhibitors. Uricosuric agents and other drugs such as lesinurad and pegloiicase ply a critical role in regulating gout symptoms and stopping prevent attacks

Full Text:

PDF

References


Neogi T. Gout. Ann Intern Med. 2016 Jul 05;165(1):ITC1-ITC16. [PubMed]

Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet. 2016 Oct 22;388(10055):2039-2052. [PubMed]

Richette P, Bardin T. Gout. Lancet. 2010 Jan 23;375(9711):318-28. [PubMed]

Nuki G, Simkin PA. A concise history of gout and hyperuricemia and their treatment. Arthritis Res Ther. 2006;8 Suppl 1(Suppl 1):S1. [PMC free article] [PubMed]

Loeb JN. The influence of temperature on the solubility of monosodium urate. Arthritis Rheum. 1972 Mar-Apr;15(2):189-92. [PubMed]

Nian YL, You CG. Susceptibility genes of hyperuricemia and gout. Hereditas. 2022 Aug 04;159(1):30. [PMC free article] [PubMed]

Merriman TR, Choi HK, Dalbeth N. The genetic basis of gout. Rheum Dis Clin North Am. 2014 May;40(2):279-90. [PubMed]

Choi HK, Mount DB, Reginato AM., American College of Physicians. American Physiological Society. Pathogenesis of gout. Ann Intern Med. 2005 Oct 04;143(7):499-516. [PubMed]

Tan PK, Farrar JE, Gaucher EA, Miner JN. Coevolution of URAT1 and Uricase during Primate Evolution: Implications for Serum Urate Homeostasis and Gout. Mol Biol Evol. 2016 Sep;33(9):2193-200. [PMC free article] [PubMed]

Abhishek A, Roddy E, Doherty M. Gout - a guide for the general and acute physicians. Clin Med (Lond). 2017 Feb;17(1):54-59. [PMC free article] [PubMed]


Refbacks

  • There are currently no refbacks.